Last reviewed · How we verify
NCT06928844
Role of Low Dose Injectable Progesterone in Triggering Ovulation
NA trial testing Progesterone in Low Dose in 120 participants. Currently enrolling.
1 August 2025
Quick facts
| Lead sponsor | The General Authority for Teaching Hospitals and Institutes |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 15 April 2025 |
| Primary completion | 1 August 2025 |
| Estimated completion | 1 August 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Progesterone (Progesterone plus HCG) — full drug profile →
- Placebo
Conditions studied
- Low Dose — all drugs for Low Dose →
- Progesterone — all drugs for Progesterone →
- Triggering Ovulation — all drugs for Triggering Ovulation →
Sponsor
The General Authority for Teaching Hospitals and Institutes
Who can join
Adults 20 to 35, female only, with Low Dose or Progesterone. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to evaluate the role of low dose injectable progesterone in triggering ovulation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06928844
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Progesterone
Trials testing the same drug.
- NCT07372495 — Cerclage Plus Progesterone vs Progesterone Alone in Twin Short Cervix · NA · not yet recruiting
- NCT06631547 — Effect of Progesterone Administration on Severely Head Injured Patients · Phase 1 · not yet recruiting
- NCT07162961 — Nintedanib for Improving Reproductive Outcomes in Adenomyosis · Phase 3 · not yet recruiting
- NCT06851754 — Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency · Phase 3 · recruiting
- NCT03637062 — Verify the Safety and Effectiveness of the Cerclage Pessary in Prevention and Treatment of High-risk Preterm Pregnancy · NA · not yet recruiting
Other The General Authority for Teaching Hospitals and Institutes trials
Trials by the same sponsor.
- NCT07295704 — Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema · recruiting
- NCT07295691 — Autologous Serum Eye Drops in Dry Eye Syndrome · NA · recruiting
- NCT07125794 — Original Denis Brawn Brace Versus Its Modification for Management of Relapsed Idiopathic Clubfoot Following Ponseti Cast · recruiting
- NCT07108712 — Diffusion Magnetic Resonance Imaging (dMRI) in the Early Evaluation of Brain White Matter Diseases · recruiting
- NCT07108725 — Non-invasive Diffusion-weighted Imaging With MRCP in the Diagnosis of Neoplastic Biliary Obstruction · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06928844 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The General Authority for Teaching Hospitals and Institutes
- Last refreshed: 16 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06928844.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing